Human Tissue Therapy – Website Content (PM)
Russell Health Intellectual Property Compliance Checklist
See full disclosure of uses of Russell Health’s intellectual property on your Account Setup & Licensing Agreement.
– Human Tissue Therapy Disclaimer must be placed on each webpage or marketing material. See Human Tissue Therapy Disclaimer document.
– No claims can be stated, promoted or marketed in anyway on marketing materials or webpage.
– All intellectual property of Russell Health can only be used to promote or market products from Russell Health.
Human Tissue Therapy products utilize human tissue allografts derived from living, healthy donors. Tissue allografts contain naturally rich growth factors to help signal the body’s healing components to assist the body with repair, reconstruction and supplementation of the recipient’s tissues. These tissues allografts are acellular, and they do not contain living, viable cells.
Human Tissue Therapy products utilize human tissue allografts (TAs) derived from living, healthy donors. Once recovered, the TA is filtered through a low-protein binding filter and terminally sterilized with gamma irradiation to ensure recipient safety. A tissue allograft is an acellular product and does not contain living, viable cells. The scientific literature describes tissue allografts as a unique source of anti-inflammatory and antimicrobial proteins. It contains known anti-inflammatory factors such as IL-1 inhibitors α & β and TIMPs. Additionally, tissue allografts are known to contain important growth factors. All research and data can be found at www.russellhealth.com/research/
Tissue Allograft characteristics as described in scientific literature:
Regulation of Inflammation
Tissue allografts are thought to regulate inflammation in the body and to help reconstruct new, healthy tissue.
Growth factors are naturally occurring in tissue allografts. Growth factors are responsible for the recruitment of the body’s healing components to promote the tissue repair and reconstruction process.
Tissue allografts are naturally occurring; they do not contain steroids or other pharmaceuticals. Because of the nature of the human tissue the potential for long-term negative health implications is limited.
Tissue allografts are thought to express immune-privileged antigens, which may reduce the risk of graft intolerance. We believe there is very little risk of foreign body reaction.
Are Tissue Allografts covered by insurance?
Yes, tissue allografts may be covered by insurances. Consult your physician to see if you are covered.
*HUMAN TISSUE THERAPY DISCLAIMER MUST BE PLACED ON THE BOTTOM OF ALL WEBPAGE AND/OR MARKETING MATERIAL.
Human Tissue Therapy Disclaimer
The treatments described on this marketing are not considered to be standard of care for any condition or disease. Human Tissue Therapy products attempt to utilize acellular, minimally manipulated tissue allografts and are comprised of tissue allograft components intended for homologous use to supplement tissue. Tissue allografts are classified by the Food and Drug Administration (FDA) as Human Cell, Tissue and Cellular and Tissue-Based Products (HCT/P) that are regulated solely under section 361 of the Public Health Service (PHS) Act. FDA recognizes that human tissue was designed, or evolved, to perform certain functions in the human body with exquisite safety and effectiveness. As an HCT/P regulated solely under the Section 361 of the PHS Act, tissue allografts are exempt from FDA premarket review, clearance, and approval from FDA. Please consult your doctor to see if a tissue allograft is right for you. No medical advice has been offered herein. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Results may vary. This human tissue should not be used for the treatment of COVID-19.